elelyso
Generic: taliglucerase alfa·Brand: Elelyso
elelyso: sourced relationships with 2 companies · 1 FDA decision.
elelyso evidence translation
What we can confirm
1 FDA record
What it means
More than one company relationship is source-backed. Until you choose one, AI stays drug-only and does not guess ownership.
What to watch
Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected
Prepared research question
What is verified about elelyso, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (3)
| Company | Dated record stage |
|---|---|
| PFIZER INC (PFE) Reported 2012-05-01 · Current development: unknownSource | Approved |
| PFIZER INC (PFE) Reported 2012-05-01 · Current development: unknownSource | Approved |
| Protalix BioTherapeutics, Inc. (PLX) | Approved |
FDA Decisions1 records
Frequently asked questions
Which companies have sourced relationships with elelyso?
elelyso has dated SEC/FDA relationship records for PFIZER INC, Protalix BioTherapeutics, Inc..
What is elelyso's latest FDA decision?
The most recent tracked FDA decision for elelyso is Approval, dated May 1, 2012.